BMS swooped on Karuna towards the end of last year, shortly after AbbVie agreed an $8.7 billion deal to acquire Cerevel ...

The 19th century was a period of immense innovation for medicine in Scotland, marked by breakthroughs in anaesthetics, ...

With 890 million people affected globally and 42% of American adults classified as obese, the allure of a "miracle" weight ...

However, the UK’s innovative ‘Netflix style’ subscription model for antibiotics represents a groundbreaking approach to ...

September is the perfect time to turn up the volume on conversations about Primary Biliary Cholangitis (PBC) and the symptoms ...

PiaSky's approval by the MHRA earlier this year was based on the COMMODORE study, which showed that the drug was equivalent ...

Aurion Biotech has launched its cell therapy Vyznova for serious eye disorder bullous keratopathy in Japan, its debut market, ...

In a landmark development, world leaders meeting at the United Nations officially adopted a political declaration on ...

It's a blow to the SCD community, as Oxbryta (voxelotor) was the first drug to reach the market that prevented sickle ...

After a long road that included a three-month delay as the agency pushed for additional data, the US FDA has approved Sanofi ...

One of the biggest market access stories this year has been the launch of Lilly Direct (and, subsequently, PfizerForAll .) ...

AstraZeneca's EGFR inhibitor Tagrisso has been approved by the FDA for a new lung cancer indication that could make it a ...